Amorepacific logo

Amorepacific

Last updated January 31, 2026
73
Innovation Areas
1,390
Inventors
15
Collaborations

Syringaresinol and ginsenoside bioactive fractions: AmorepacificRecent Research Landscape

Inconsistent bioactivity in raw herbal extracts leads to unpredictable therapeutic efficacy, which is mitigated by isolating and concentrating specific ginsenoside isomers. This precise molecular control ensures standardized anti-inflammatory and metabolic potency for pharmaceutical applications.

What technical problems is Amorepacific addressing in Syringaresinol and ginsenoside bioactive fractions?

Environmental and physiological stress damage

(13)evidences

Pathological inflammatory responses and metabolic dysregulation lead to tissue damage and obesity. Reducing these biological stressors prevents chronic disease progression.

Suboptimal physiological resilience

(4)evidences

Biological systems exhibit systemic failure modes during chronic stress and aging. Addressing these physiological deficits restores homeostasis and prevents functional decline.

Low bioactive ingredient purity

(2)evidences

Natural bioactive compounds are targeted to address low biological defense activity. Improving the potency of extracted fractions overcomes baseline physiological limitations in immune modulation.